UPDATED Jun 20, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
A336570 | ₩8,320.00 | 3.4% | -19.4% | ₩743.3b | ₩12,666.67 | PE22.6x | E31.5% | 0.6% | ||
CDX | AU$0.078 | 36.8% | -54.1% | AU$19.4m | n/a | PS1.6x | E115.3% | n/a | ||
688358 | CN¥26.90 | -0.7% | -52.6% | CN¥3.0b | n/a | PE21.6x | E32.8% | 3.0% | ||
1858 | HK$9.33 | -2.8% | -38.8% | HK$5.5b | HK$22.98 | PE12x | E24.7% | 4.2% | ||
DIGN | kr1.50 | -5.7% | -60.5% | kr120.8m | kr8.60 | PS1.4x | E157.4% | n/a | ||
ARCOMA | kr16.80 | 4.3% | 68.0% | kr221.5m | kr15.00 | PE23.6x | E20.5% | n/a | ||
MEDHLP | kr2.86 | 1.4% | -22.3% | kr87.0m | n/a | PB3.4x | E87.4% | n/a | ||
LFMD | US$7.21 | -11.2% | 97.5% | US$332.8m | US$12.83 | PS1.9x | E126.2% | n/a | ||
NXTMH | €2.97 | -7.2% | -15.9% | €20.1m | €3.40 | PS2.3x | E67.8% | n/a | ||
301015 | CN¥25.89 | -10.0% | -2.9% | CN¥13.6b | CN¥48.00 | PE20.7x | E22.6% | 2.9% | ||
ENOV | US$44.56 | -0.8% | -26.1% | US$2.4b | US$72.18 | PS1.3x | E91.1% | n/a | ||
INSP | US$167.71 | 0.3% | -47.3% | US$4.8b | US$248.07 | PS7.5x | E53.1% | n/a | ||
SGRY | US$23.69 | -6.4% | -42.7% | US$3.2b | US$41.09 | PE4989.3x | E48.8% | n/a | ||
ARJO B | kr42.28 | -5.3% | 7.9% | kr11.5b | kr51.25 | PE23.1x | E21.4% | 2.1% | ||
AUNA | US$8.04 | 4.0% | n/a | US$592.1m | US$16.05 | PB1.4x | E51.7% | n/a | ||
ZYXI | US$9.18 | 0.5% | -3.0% | US$290.4m | US$21.00 | PE35.7x | E37.3% | n/a | ||
MNTC | kr29.40 | 8.1% | -25.2% | kr751.7m | kr45.00 | PS2.9x | E74.1% | 0% | ||
853 | HK$5.98 | -3.1% | -52.2% | HK$11.0b | HK$12.14 | PS1.5x | E71.3% | n/a | ||
2407 | HK$13.80 | -2.7% | -69.3% | HK$2.0b | HK$30.00 | PE11x | E23.6% | 7.9% | ||
EVH | US$22.03 | -1.7% | -24.8% | US$2.5b | US$41.36 | PS1.2x | E62.5% | n/a | ||
MATD3 | R$4.60 | -5.5% | -58.7% | R$1.8b | R$8.79 | PE13.1x | E20.3% | 1.5% | ||
ONCO3 | R$5.67 | -6.4% | -42.1% | R$3.0b | R$12.94 | PE13.7x | E38.8% | n/a | ||
MED | CHF70.70 | 0% | -0.6% | CHF960.2m | CHF98.98 | PE1551.1x | E60.4% | n/a | ||
VMD | US$6.51 | -8.8% | -32.2% | US$256.6m | US$12.75 | PE24.5x | E32.2% | n/a |